US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GSK plc ADRhedged

69.79

-0.0140-0.02%

Post-market: 69.790.00000.00%16:10 EDT

Volume:315

Turnover:21.91K

Market Cap:697.95K

PE:- -

High:69.83

Open:69.50

Low:69.38

Close:69.80

52wk High:85.03

52wk Low:55.75

Shares:10.00K

Float Shares:10.00K

Volume Ratio:1.02

T/O Rate:3.15%

Dividend:2.08

Dividend Rate:2.98%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Dow Jones Top Company Headlines at 3 am ET: Sino Biopharm Strikes Drug Licensing Deal with Astrazeneca, Deepens GSK Partnership | White ...

Sino Biopharm Deepens GSK Respiratory Deal to Cement China Lead

GSK’s StrateGIST Frontline Trial Puts New Cancer Drug Velzatinib in the Spotlight

HANXBIO-B Forges Strategic Alliance to Pioneer AI-Enhanced Drug Discovery Framework

Drug Pricing Pressure Puts GSK And Global Pharma Stocks In Focus

Simply Wall St.

Pharmaceutical Sector Attracts Capital Rotation, GlaxoSmithKline Surges Nearly 5%

GSK’s New mRNA Combo Shot Targets Flu and COVID-19 in One Vaccine

GSK Completes £2 Billion Share Buyback, Lifts Treasury Holdings to 6.7% of Voting Rights

GlaxoSmithKline (GSK) Gets a Sell from Barclays

GSK’s Extended Salford Lung Study: What a Terminated Data Project Still Means for Investors

Dodge & Cox lifts GSK stake above 5% as institutional backing grows

GSK Advances BALANCE Trial: New IBS Drug Candidate Moves Through Mid‑Stage Testing

GSK’s MODIFY Asthma Trial: Early Biologic Bet With Long-Term Upside Potential

Gsk's HIV Franchise Seems Underappreciated

GSK Revamps Belantamab Dosing in New Multiple Myeloma Study: What Investors Should Watch

GSK Unit Launches Tender Offer for Nuvalent Acquisition

MT Newswires Live

GSK Discloses Executive Notional ADS Acquisition by U.S. President

GSK launches $124-per-share tender offer to acquire oncology developer Nuvalent

GSK board members boost holdings with coordinated share purchases

GSK's Nuvalent Deal Could Be Rare Case of Profitable Oncology Acquisition -- Market Talk

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/GSKH/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GSKH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","market":"US","secType":"STK","nameCN":"GSK plc ADRhedged","latestPrice":69.7885,"timestamp":1789502400000,"preClose":69.8025,"halted":0,"volume":315,"hourTrading":{"tag":"盘后","latestPrice":69.7885,"preClose":69.7885,"latestTime":"16:10 EDT","volume":6,"amount":418.731,"timestamp":1789503007262,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.00020056588231074523,"floatShares":10001,"shares":10001,"eps":0,"marketStatus":"Post-Mkt","change":-0.014,"latestTime":"09-15 16:26:56 EDT","open":69.5,"high":69.83,"low":69.38,"amount":21910,"amplitude":0.006447,"askPrice":104.74,"askSize":200,"bidPrice":34.92,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789516800000},"marketStatusCode":4,"adr":0,"exchange":"ARCA","adjPreClose":69.8025,"nav":66.979706,"aum":669864.039706,"dividendRate":0.029806,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":69.7885,"preClose":69.7885,"latestTime":"16:10 EDT","volume":6,"amount":418.731,"timestamp":1789503007262,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.024724,"impliedVol":0.3521,"impliedVolPercentile":0.9739},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","floatShares":10001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.024724,"shares":10001,"dividePrice":2.0801,"high":69.83,"amplitude":0.006447,"preClose":69.8025,"low":69.38,"week52Low":55.7526,"pbRate":"--","week52High":85.03,"institutionHeld":0,"latestPrice":69.7885,"eps":0,"divideRate":0.029806,"volume":315,"delay":0,"ttmEps":0,"open":69.5,"prevYearClose":68.2031,"prevWeekClose":66.9705,"prevMonthClose":69.8569,"prevQuarterClose":73.8574,"fiveDayClose":67.5659,"twentyDayClose":69.8844,"sixtyDayClose":71.9341},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSKH\",params:#limit:5,,,undefined,":[{"date":"2026-06-16","symbol":"GSKH","amount":0.92785,"announcedDate":"2026-06-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-16","defaultRemindTime":1781616600000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-16","currency":"USD","dateTimestamp":1781582400000,"payDate":"2026-06-23"},{"date":"2026-03-16","symbol":"GSKH","amount":0.36332,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"GSKH","amount":0.78682,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSKH\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.78682,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.36332,"currency":"USD"},{"executeDate":"2026-06-16","recordDate":"2026-06-16","paymentDate":"2026-06-23","value":0.92785,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GSKH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSKH\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2649637389","title":"Dow Jones Top Company Headlines at 3 am ET: Sino Biopharm Strikes Drug Licensing Deal with Astrazeneca, Deepens GSK Partnership | White ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2649637389","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649637389?lang=en_us&edition=fundamental","pubTime":"2026-07-08 15:00","pubTimestamp":1783494000,"startTime":"0","endTime":"0","summary":"Sino Biopharm Strikes Drug Licensing Deal With AstraZeneca, Deepens GSK PartnershipSino Biopharmaceutical will receive $200 million upfront from AstraZeneca, and will be eligible for milestone payment","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4590","EMLP","ET","EIPI","UMI","BK4532","MLPA","BK4007","BK4144","BK4585","AMLP","BK4581","BK4561","USAI","ENFR","AMZA","GSK","GSK.UK","LU1829250122.USD","GSKH","MDST","EIPX","BK4588","TPZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649616957","title":"Sino Biopharm Deepens GSK Respiratory Deal to Cement China Lead","url":"https://stock-news.laohu8.com/highlight/detail?id=2649616957","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649616957?lang=en_us&edition=fundamental","pubTime":"2026-07-08 12:07","pubTimestamp":1783483636,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical ( ($HK:1177) ) just unveiled an announcement. Sino Biopharmaceutical is a leading Chinese pharmaceutical group with a strong...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sino-biopharm-deepens-gsk-respiratory-deal-to-cement-china-lead?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sino-biopharm-deepens-gsk-respiratory-deal-to-cement-china-lead?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSKH","BK4585","GSK","LU1829250122.USD","DBB","BK4007","BK4588","BK4532","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649931584","title":"GSK’s StrateGIST Frontline Trial Puts New Cancer Drug Velzatinib in the Spotlight","url":"https://stock-news.laohu8.com/highlight/detail?id=2649931584","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649931584?lang=en_us&edition=fundamental","pubTime":"2026-07-08 00:30","pubTimestamp":1783441817,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline is launching a Phase 3 study called StrateGIST Frontlin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-strategist-frontline-trial-puts-new-cancer-drug-velzatinib-in-the-spotlight?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-strategist-frontline-trial-puts-new-cancer-drug-velzatinib-in-the-spotlight?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","BK4007","LU1829250122.USD","GSKH","GSK","BK4532","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173871150","title":"HANXBIO-B Forges Strategic Alliance to Pioneer AI-Enhanced Drug Discovery Framework","url":"https://stock-news.laohu8.com/highlight/detail?id=1173871150","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173871150?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:12","pubTimestamp":1783422743,"startTime":"0","endTime":"0","summary":"HANXBIO-B has announced a strategic partnership aimed at harnessing the power of artificial intelligence to revolutionize the drug development process.The company has entered into a formal agreement...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIPO","QTOC","ARTY","BK1173","WRND","LFSC","BK4585","BK1161","BK1535","CHAT","03378","BBP","GDOC","SBIO","IBB","GSKH","BK4588","VTHR","PBE","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649163671","title":"Drug Pricing Pressure Puts GSK And Global Pharma Stocks In Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2649163671","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649163671?lang=en_us&edition=fundamental","pubTime":"2026-07-07 04:34","pubTimestamp":1783370099,"startTime":"0","endTime":"0","summary":"Global pharma is back in the political spotlight, as US pressure on drug prices abroad collides with European cost controls and fresh trade tensions. For investors, this mix of policy risk and pricing shifts could change how large pharmaceutical stocks are viewed, especially those with significant US and European exposure. This article looks at three large-cap global pharmaceutical companies from our screener that appear especially exposed to the latest headlines, and explains why some...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/275442-main-header/1585186835888","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/275442-main-header/1585186835888"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/gb/pharmaceuticals-biotech/lse-gsk/gsk-shares/news/drug-pricing-pressure-puts-gsk-and-global-pharma-stocks-in-f","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/gb/pharmaceuticals-biotech/lse-gsk/gsk-shares/news/drug-pricing-pressure-puts-gsk-and-global-pharma-stocks-in-f","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IHE","LU0058720904.USD","IE00BJT1NW94.SGD","LU1894683348.USD","LU0994945656.USD","FHLC","XLV","FTXH","IE00BSNM7G36.USD","IE00B3PB1722.GBP","LU1839511570.USD","LU1732799900.SGD","LU1196500208.SGD","LU1032466523.USD","VHT","IE00B7SZLL34.SGD","LU1496350502.SGD","MEDX","BK4559","GDOC","LU2471134796.USD","BMED","LU1935042991.SGD","LU1244550577.SGD","LU2505996681.GBP","LU0912757837.SGD","PJP","LU2430703251.USD","LU1228905540.USD","RXL","IE000SO60NU8.SGD","JNJ","LU0466842654.USD","LU1023059063.AUD","LU1280957306.USD","JDOC","LU2347655156.SGD","LU2750360641.GBP","VTRS","IE000MB6IJN5.SGD","IXJ","LU2468319806.SGD","LU2471134523.USD","GSK","GSK.UK","LU1983299246.USD","LU2023250330.USD","GSKH","IYH","LU1074936037.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137018709","title":"Pharmaceutical Sector Attracts Capital Rotation, GlaxoSmithKline Surges Nearly 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1137018709","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137018709?lang=en_us&edition=fundamental","pubTime":"2026-07-02 23:47","pubTimestamp":1783007267,"startTime":"0","endTime":"0","summary":"The pharmaceutical sector is once again experiencing a rotation of capital inflows.GlaxoSmithKline PLC (GSK.US) shares are up nearly 5%. Novo Nordisk A/S (NVO.US) and Sanofi (SNY.US) have gained more...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK","BK4532","09939","BK4588","BK4007","BK1161","LU1829250122.USD","BK1574","GSK.UK","GSKH","BK4585","159938","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648620563","title":"GSK’s New mRNA Combo Shot Targets Flu and COVID-19 in One Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2648620563","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648620563?lang=en_us&edition=fundamental","pubTime":"2026-07-01 00:30","pubTimestamp":1782837058,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GSK Tests Dual mRNA Vaccine for Flu and COVID-19 in Older Adults. The s...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-new-mrna-combo-shot-targets-flu-and-covid-19-in-one-vaccine?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-new-mrna-combo-shot-targets-flu-and-covid-19-in-one-vaccine?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","LU1829250122.USD","BK4535","GSK.UK","BNTX","BK4532","BK4568","BK4139","BK4007","BK4585","GSKH","GSK","BK4548","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647370385","title":"GSK Completes £2 Billion Share Buyback, Lifts Treasury Holdings to 6.7% of Voting Rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2647370385","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647370385?lang=en_us&edition=fundamental","pubTime":"2026-06-29 22:03","pubTimestamp":1782741803,"startTime":"0","endTime":"0","summary":"An announcement from GlaxoSmithKline ( ($GB:GSK) ) is now available. GSK has completed a share buyback programme of up to £2 billion, executed thro...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-completes-2-billion-share-buyback-lifts-treasury-holdings-to-6-7-of-voting-rights?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-completes-2-billion-share-buyback-lifts-treasury-holdings-to-6-7-of-voting-rights?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4532","GSKH","LU1829250122.USD","BK4588","GSK","GSK.UK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647332685","title":"GlaxoSmithKline (GSK) Gets a Sell from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2647332685","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647332685?lang=en_us&edition=fundamental","pubTime":"2026-06-29 14:35","pubTimestamp":1782714923,"startTime":"0","endTime":"0","summary":"Barclays analyst James Gordon CFA maintained a Sell rating on GlaxoSmithKline today and set a price target of £19.00. Gordon CFA covers the Healthc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-sell-from-barclays-blurbs-news-5?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-sell-from-barclays-blurbs-news-5?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","GSKH","BK4588","LU1829250122.USD","BK4532","CFA","GSK","GSK.UK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646361946","title":"GSK’s Extended Salford Lung Study: What a Terminated Data Project Still Means for Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2646361946","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646361946?lang=en_us&edition=fundamental","pubTime":"2026-06-27 00:30","pubTimestamp":1782491419,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. The Extended Salford Lung Study (Ex-SLS) Data Access Project from GSK t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-extended-salford-lung-study-what-a-terminated-data-project-still-means-for-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-extended-salford-lung-study-what-a-terminated-data-project-still-means-for-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4585","LU1829250122.USD","ISBC","GSK","BK4532","GSKH","GSK.UK","BK4211","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646365150","title":"Dodge & Cox lifts GSK stake above 5% as institutional backing grows","url":"https://stock-news.laohu8.com/highlight/detail?id=2646365150","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646365150?lang=en_us&edition=fundamental","pubTime":"2026-06-26 22:28","pubTimestamp":1782484090,"startTime":"0","endTime":"0","summary":"The latest update is out from GlaxoSmithKline ( ($GSK) ). On 23 June 2026, U.S. investment manager Dodge & Cox increased its stake in GSK plc, cros...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dodge-cox-lifts-gsk-stake-above-5-as-institutional-backing-grows?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dodge-cox-lifts-gsk-stake-above-5-as-institutional-backing-grows?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","GSK","BK4532","LU1829250122.USD","BK4588","BK4585","BK4007","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646027078","title":"GSK Advances BALANCE Trial: New IBS Drug Candidate Moves Through Mid‑Stage Testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2646027078","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646027078?lang=en_us&edition=fundamental","pubTime":"2026-06-26 00:31","pubTimestamp":1782405113,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline is running the BALANCE Phase 2b study to test camlipixa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-advances-balance-trial-new-ibs-drug-candidate-moves-through-midstage-testing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-advances-balance-trial-new-ibs-drug-candidate-moves-through-midstage-testing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","BK4007","GSKH","LU1829250122.USD","GSK","BK4532","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646020628","title":"GSK’s MODIFY Asthma Trial: Early Biologic Bet With Long-Term Upside Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2646020628","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646020628?lang=en_us&edition=fundamental","pubTime":"2026-06-26 00:31","pubTimestamp":1782405105,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline is running the Phase 3b/4 MODIFY study to test early us...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-modify-asthma-trial-early-biologic-bet-with-long-term-upside-potential?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-modify-asthma-trial-early-biologic-bet-with-long-term-upside-potential?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK","BK4588","BK4585","GSK.UK","LU1829250122.USD","BK4007","BK4532","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646824383","title":"Gsk's HIV Franchise Seems Underappreciated","url":"https://stock-news.laohu8.com/highlight/detail?id=2646824383","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646824383?lang=en_us&edition=fundamental","pubTime":"2026-06-25 14:06","pubTimestamp":1782367560,"startTime":"0","endTime":"0","summary":"0605 GMT - HIV treatments look set to undergo a major transformation in the coming decades, and GSK's potential in this market seems underappreciated, Bernstein analysts say in a research note. With Britain's GSK and American rival Gilead Sciences commanding a combined 90% share of the U.S. HIV market, this is essentially a duopoly, according to Bernstein. Existing HIV drugs are already very effective, but upcoming innovations that will help move patients to long-acting injectable drugs from daily tablets is expected to drive future market growth, the analysts say. The U.S. HIV market is expected to grow to $37 billion in 2040, up from $26 billion last year, with GSK's share projected to rise to 44% from 26% over the same time horizon, they estimate.  Dow Jones NewswiresJune 25, 2026 02:06 ET Copyright  2026 Dow Jones & Company, Inc.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0114720955.EUR","LU1066051498.USD","LU0058720904.USD","LU1674673691.USD","LU1037948541.HKD","LU1023059063.AUD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU1934455194.USD","BK4550","SG9999015978.USD","BK4585","GSK.UK","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU1430594728.SGD","LU1066053197.SGD","LU1829250122.USD","BK4583","GSK","LU0320765992.SGD","SG9999015952.SGD","LU1674673428.USD","IE00BSNM7G36.USD","BK4588","GILD","IE00B3T34201.USD","IE0002270589.USD","BK4007","LU1061106388.HKD","LU0234570918.USD","LU0122379950.USD","GSKH","LU1037948897.HKD","BK4566","LU0861579265.USD","LU1839511570.USD","LU1934455863.HKD","BK4568","IE00B7SZLL34.SGD","LU0823416689.USD","LU2324357040.USD","BK4578","SG9999015986.USD","LU0965509283.SGD","BK4532","LU2089984988.USD","SG9999015945.SGD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646812246","title":"GSK Revamps Belantamab Dosing in New Multiple Myeloma Study: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2646812246","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646812246?lang=en_us&edition=fundamental","pubTime":"2026-06-25 00:31","pubTimestamp":1782318667,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GSK Tests New Dosing for Key Myeloma Drug in Phase 2 Trial. This new st...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-revamps-belantamab-dosing-in-new-multiple-myeloma-study-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-revamps-belantamab-dosing-in-new-multiple-myeloma-study-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU1829250122.USD","GSK.UK","BK4588","BK4532","BK4211","ISBC","GSKH","BK4007","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646781288","title":"GSK Unit Launches Tender Offer for Nuvalent Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2646781288","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646781288?lang=en_us&edition=fundamental","pubTime":"2026-06-25 00:02","pubTimestamp":1782316952,"startTime":"0","endTime":"0","summary":"GSK  said Wednesday its Harmony Row Acquisition unit commenced a tender offer to purchase all outstanding Class A and Class B shares of Nuvalent  for $124 per share in cash.Following the consummation of the offer, the unit will merge into Nuvalent, which will continue as a direct wholly-owned subsidiary of GlaxoSmithKline LLC.Nuvalent's board of directors recommended that stockholders accept the offer and tender their shares, GSK said.The tender offer and withdrawal rights will expire on July 14, the company added.Price: 51.20, Change: -0.87, Percent Change: -1.67","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GSK.UK","BK4139","BK4585","GSK","LU1829250122.USD","BK4588","GSKH","BK4532","BK4007","NUVL","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645811812","title":"GSK Discloses Executive Notional ADS Acquisition by U.S. President","url":"https://stock-news.laohu8.com/highlight/detail?id=2645811812","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645811812?lang=en_us&edition=fundamental","pubTime":"2026-06-24 22:32","pubTimestamp":1782311549,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has shared an update. GSK has disclosed a transaction involving Maya Martinez-Davis, President of its U.S. business, ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-discloses-executive-notional-ads-acquisition-by-u-s-president?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-discloses-executive-notional-ads-acquisition-by-u-s-president?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","GSK.UK","BK4007","BK4532","BK4588","GSK","LU1829250122.USD","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645781620","title":"GSK launches $124-per-share tender offer to acquire oncology developer Nuvalent","url":"https://stock-news.laohu8.com/highlight/detail?id=2645781620","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645781620?lang=en_us&edition=fundamental","pubTime":"2026-06-24 21:58","pubTimestamp":1782309489,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) just unveiled an update. GSK has launched a cash tender offer, through its subsidiary Harmony Row Acquisition Co., to...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-launches-124-per-share-tender-offer-to-acquire-oncology-developer-nuvalent?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-launches-124-per-share-tender-offer-to-acquire-oncology-developer-nuvalent?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4007","GSKH","BK4585","GSK","NUVL","BK4532","BK4139","LU1829250122.USD","GSK.UK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645837762","title":"GSK board members boost holdings with coordinated share purchases","url":"https://stock-news.laohu8.com/highlight/detail?id=2645837762","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645837762?lang=en_us&edition=fundamental","pubTime":"2026-06-23 23:07","pubTimestamp":1782227251,"startTime":"0","endTime":"0","summary":"An update from GlaxoSmithKline ( ($GB:GSK) ) is now available. GSK has disclosed a series of share purchases by its senior board members, including...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-board-members-boost-holdings-with-coordinated-share-purchases?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-board-members-boost-holdings-with-coordinated-share-purchases?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSKH","BK4007","LU1829250122.USD","BK4585","BK4532","GSK","GSK.UK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645888836","title":"GSK's Nuvalent Deal Could Be Rare Case of Profitable Oncology Acquisition -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2645888836","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645888836?lang=en_us&edition=fundamental","pubTime":"2026-06-23 13:58","pubTimestamp":1782194280,"startTime":"0","endTime":"0","summary":"0557 GMT - GSK's proposed acquisition of Nuvalent could be a rare case of an oncology deal by a big pharmaceutical company at an excellent price that turns out to be profitable, Bernstein analysts say in a research note. Nuvalent's most advanced products--lung-cancer drugs candidates neladalkib and zidesamtinib--could generate total peak revenue of $9.8 billion, according to Bernstein. This is 56% higher than the current consensus forecast, the analysts say. The incremental sales should be very profitable for GSK, which leads Bernstein to estimate Nuvalent could lift GSK's 2036 adjusted EPS by 18%. \"We thus see this [acquisition] as another crucial piece in the jigsaw which restores GSK to sustainable growth and transforms investors' perceptions,\" the analysts say. ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","BK4585","GSK","BK4532","GSK.UK","LU1829250122.USD","GSKH","BK4539","NUVL","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}